Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV002956136 | SCV003683473 | uncertain significance | Inborn genetic diseases | 2021-07-09 | criteria provided, single submitter | clinical testing | The c.7219G>C (p.E2407Q) alteration is located in exon 50 (coding exon 50) of the PIEZO1 gene. This alteration results from a G to C substitution at nucleotide position 7219, causing the glutamic acid (E) at amino acid position 2407 to be replaced by a glutamine (Q). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |
Ce |
RCV003312085 | SCV004010521 | uncertain significance | not provided | 2023-05-01 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV003312085 | SCV004260912 | benign | not provided | 2022-10-29 | criteria provided, single submitter | clinical testing | |
OMIM | RCV003152653 | SCV003841040 | affects | Blood group, ER | 2023-01-26 | no assertion criteria provided | literature only |